BioSpace News Archive

Eton Pharmaceuticals, Inc., an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced that it will report second quarter 2023 financial results on Thursday, August 10, 2023.

Ovid Therapeutics Inc. today announced that management will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on August 7, 2023, at 9:30 a.m. ET.

Pasithea Therapeutics Corp. announced a publication in the internationally renowned scientific peer-reviewed journal Proceedings of the National Academy of Sciences, related to its PAS-003 drug discovery program, that describes an increased expression of α5/β1 integrin on motor neurons in ALS human and mouse tissue, as well as the blockade of this integrin as a potential new approach to treat ALS patients.

Immutep Limited today announces it has received positive scientific advice from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for the continued development of eftilagimod alpha (efti).

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that InMode will participate at the following investor conferences and events in August.

Foldax® , Inc., a leader in the development of innovative, polymer heart valves, today announced that the first 30 patients have been treated outside of the U.S., in the Indian clinical trial of the TRIA™ surgical mitral heart valve.

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in three upcoming investor conferences.

Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene and its polymer, poly p-hydroxystyrene, using a combination of biosynthesis, chemosynthesis, and polymerization.

Metrion Biosciences Limited announced it has received notification from the UK’s Medicines and Healthcare products Regulatory Agency that the Company is now a member of the UK GLP Compliance Monitoring Programme, and is therefore able to offer GLP compliant hERG ion channel screening services to the global life sciences community.

United BioSource, LLC, the leading provider of evidence-based research for the biopharma industry, has migrated its safety functions from on-premises to Oracle Argus Cloud Service, a trusted safety case management solution.